Pyrimidine News and Research

RSS
Study explores broad-spectrum, host-acting antiviral strategy to treat SARS-CoV-2

Study explores broad-spectrum, host-acting antiviral strategy to treat SARS-CoV-2

Researchers identify a powerful combination of antivirals to treat COVID-19

Researchers identify a powerful combination of antivirals to treat COVID-19

Researchers identify a potent new combination of antiviral drugs to combat SARS-CoV-2

Researchers identify a potent new combination of antiviral drugs to combat SARS-CoV-2

Host kinase identified as an inhibition target for SARS-CoV-2

Host kinase identified as an inhibition target for SARS-CoV-2

Screening FDA-approved compounds shown to possess antiviral or antimicrobial activity for SARS-CoV-2 inhibition

Screening FDA-approved compounds shown to possess antiviral or antimicrobial activity for SARS-CoV-2 inhibition

Impact of ultraviolet disinfection on nosocomial transmission of SARS-CoV-2 and other infectious diseases

Impact of ultraviolet disinfection on nosocomial transmission of SARS-CoV-2 and other infectious diseases

Development of light-based tool for the inactivation of SARS-CoV-2

Development of light-based tool for the inactivation of SARS-CoV-2

Study finds FDA-approved drug has potent antiviral activity against SARS-CoV-2 and variants of concern

Study finds FDA-approved drug has potent antiviral activity against SARS-CoV-2 and variants of concern

Inhibition of SARS-CoV-2 helicase by single DNA lesions

Inhibition of SARS-CoV-2 helicase by single DNA lesions

Study uncovers a subset of human short introns spliced out by a distinct mechanism

Study uncovers a subset of human short introns spliced out by a distinct mechanism

SARS-CoV-2 inhibited by pyrimidine biosynthesis inhibitors in conjunction with nucleoside analogs

SARS-CoV-2 inhibited by pyrimidine biosynthesis inhibitors in conjunction with nucleoside analogs

Novel PF74 molecule effectively targets HIV capsid protein

Novel PF74 molecule effectively targets HIV capsid protein

Acrylamide-based novel DHODH inhibitors as potential treatment for rheumatoid arthritis

Acrylamide-based novel DHODH inhibitors as potential treatment for rheumatoid arthritis

Acrylamide-based DHODH inhibitors are potential agents for treating rheumatoid arthritis

Acrylamide-based DHODH inhibitors are potential agents for treating rheumatoid arthritis

MEDS433 hinders SARS-CoV-2 replication

MEDS433 hinders SARS-CoV-2 replication

PTC299 inhibits SARS-CoV-2 replication and suppresses production of inflammatory cytokines

PTC299 inhibits SARS-CoV-2 replication and suppresses production of inflammatory cytokines

DNA damage may occur far away from the point of incidence of radiation

DNA damage may occur far away from the point of incidence of radiation

DHODH inhibitor PTC299 shows potential as a COVID-19 therapeutic

DHODH inhibitor PTC299 shows potential as a COVID-19 therapeutic

New genome-editing technologies can help understand disease-associated genetic mutations

New genome-editing technologies can help understand disease-associated genetic mutations

Specific SARS-CoV-2 genetic elements found in different insect species

Specific SARS-CoV-2 genetic elements found in different insect species